|
|
Volumn 8, Issue 2, 2008, Pages 122-
|
|
Editorial
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
6 N (3,3 DIMETHYLALLYL)ADENOSINE;
ANTHRACYCLINONE DERIVATIVE;
ANTINEOPLASTIC AGENT;
BLEOMYCIN;
CALICHEAMICIN;
CAMPTOTHECIN;
DACTINOMYCIN;
DAUNORUBICIN;
DOXORUBICIN;
DYNAMYCINE;
ENEDIYNE;
IRINOTECAN;
LINDAMYCIN;
MITOMYCIN;
NATURAL PRODUCT;
PACLITAXEL;
POLYPHENOL;
TOPOTECAN;
BIOLOGICAL FACTOR;
ANTINEOPLASTIC ACTIVITY;
BARK;
CANCER MORTALITY;
CANCER RADIOTHERAPY;
CANCER RISK;
CANCER SCINTISCANNING;
CELL DIVISION;
CELL INVASION;
CLINICAL TRIAL;
DNA BINDING;
DRUG SYNTHESIS;
EDITORIAL;
HUMAN;
MALIGNANT NEOPLASTIC DISEASE;
METASTASIS;
MOLECULAR BIOLOGY;
STRUCTURE ACTIVITY RELATION;
UNSPECIFIED SIDE EFFECT;
ADJUVANT CHEMOTHERAPY;
CHEMISTRY;
NEOPLASM;
ANTINEOPLASTIC AGENTS;
BIOLOGICAL FACTORS;
CHEMOTHERAPY, ADJUVANT;
HUMANS;
NEOPLASMS;
|
|
EID: 44449105707
PISSN: 18715206
EISSN: None
Source Type: Journal
DOI: 10.2174/187152008783497019 Document Type: Editorial |
|
Times cited : (3)
|
|
References (0)
|
